Larimar Therapeutics, Inc.

NASDAQ
LRMR
Stock
Yield per half year: -71.84%
Dividend yield: 0%
Sector: Healthcare

Share chart Larimar Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Larimar Therapeutics, Inc.

Larimar Therapeutics, Inc., биотехнологическая компания клинической стадии, специализируется на разработке методов лечения редких заболеваний с использованием своей новой технологической платформы пептидов, проникающих в клетки. Его ведущим продуктом-кандидатом является CTI-1601, который находится на стадии 2 клинических испытаний для лечения атаксии Фридрейха, редкого, прогрессирующего и смертельного генетического заболевания. Штаб-квартира компании находится в Бала-Синвид, штат Пенсильвания.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 2014-06-19
ISIN US5171251003
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 1.87
Change price per day: 0% (1.87)
Change price per week: -9.22% (2.06)
Change price per month: -19.74% (2.33)
Change price per 3 month: -36.61% (2.95)
Change price per half year: -71.84% (6.64)
Change price per year: -74.66% (7.38)
Change price per 3 year: -31.75% (2.74)
Change price per 5 year: +136.86% (0.7895)
Change price per 10 year: -95.17% (38.74)
Change price per year to date: -50.53% (3.78)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 1.38 9
P/E 0 0
EV/EBITDA -2.6 0
Total: 3.63
Efficiency
Title Value Grade
ROA, % -54.43 0
ROE, % -63.58 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.0637 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 87.57 9
Yield EPS, % -62.77 0
Total: 5.2
More

Main owners

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 16 941 357 26.62
Blue Owl Capital Holdings LP 3 414 468 5.37
Verition Fund Management, LLC 2 811 131 4.42
Janus Henderson Group PLC 2 641 065 4.15
Blackrock Inc. 1 668 045 2.62
Vanguard Group Inc 1 455 243 2.29
Adage Capital Partners GP L.L.C. 1 276 680 2.01
Mangrove Partners 805 815 1.27
Woodline Partners LP 796 226 1.25
Stempoint Capital LP 783 172 1.23

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Dr. Carole S. Ben-Maimon M.D. CEO, President & Director 845.63k 1959 (66 years)
Mr. Michael Celano CPA Secretary & CFO 562.62k 1959 (66 years)
Mr. John Berman Vice President of Finance & Administration N/A
Ms. Jennifer Spokes Johansson Vice President of Legal & Compliance N/A
Dr. Gopi Shankar M.B.A., Ph.D. Chief Development Officer N/A 1971 (54 years)
Mr. Francis Michael Conway CPA VP & Controller N/A
Dr. Russell G. Clayton Sr., D.O, D.O. Chief Medical Officer 1961 (64 years)

About company

Address: United States, Bala Cynwyd. PA, Three Bala Plaza East - Open in google maps, Open in yandex maps
Website: https://www.larimartx.com